126 related articles for article (PubMed ID: 30578902)
1. KDM3A is associated with tumor metastasis and modulates colorectal cancer cell migration and invasion.
Liu J; Liang T; Zhangsun W
Int J Biol Macromol; 2019 Apr; 126():318-325. PubMed ID: 30578902
[TBL] [Abstract][Full Text] [Related]
2. The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis.
Sechler M; Parrish JK; Birks DK; Jedlicka P
Oncogene; 2017 Jul; 36(29):4150-4160. PubMed ID: 28319067
[TBL] [Abstract][Full Text] [Related]
3. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
Ramadoss S; Guo G; Wang CY
Oncogene; 2017 Jan; 36(1):47-59. PubMed ID: 27270439
[TBL] [Abstract][Full Text] [Related]
4. [Knockdown of lysine-specific demethylase 3A (KDM3A) inhibits the invasion and migration of MDA-MB-231 breast cancer cells and arrests the cell cycle in the G0/G1 phase].
Gao W; Zhang T; Yao J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Sep; 37(9):808-814. PubMed ID: 34533128
[TBL] [Abstract][Full Text] [Related]
5. Histone demethylase KDM3A is required for enhancer activation of hippo target genes in colorectal cancer.
Wang HY; Long QY; Tang SB; Xiao Q; Gao C; Zhao QY; Li QL; Ye M; Zhang L; Li LY; Wu M
Nucleic Acids Res; 2019 Mar; 47(5):2349-2364. PubMed ID: 30649550
[TBL] [Abstract][Full Text] [Related]
6. KDM1A and KDM3A promote tumor growth by upregulating cell cycle-associated genes in pancreatic cancer.
Hou X; Li Q; Yang L; Yang Z; He J; Li Q; Li D
Exp Biol Med (Maywood); 2021 Sep; 246(17):1869-1883. PubMed ID: 34171978
[TBL] [Abstract][Full Text] [Related]
7. MiR-22-3p regulates the proliferation, migration and invasion of colorectal cancer cells by directly targeting KDM3A through the Hippo pathway.
Jin RR; Zeng C; Chen Y
Histol Histopathol; 2022 Dec; 37(12):1241-1252. PubMed ID: 36173030
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
[TBL] [Abstract][Full Text] [Related]
9. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
10. Knockout of KDM3A in MDA-MB-231 breast cancer cells inhibits tumor malignancy and promotes apoptosis.
Han Y; Maimaiti N; Sun Y; Yao J
J Mol Histol; 2024 Feb; 55(1):139-148. PubMed ID: 38165573
[TBL] [Abstract][Full Text] [Related]
11. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
Ramadoss S; Sen S; Ramachandran I; Roy S; Chaudhuri G; Farias-Eisner R
Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients.
Qi P; Xu MD; Ni SJ; Shen XH; Wei P; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
Mol Carcinog; 2015 Sep; 54(9):742-50. PubMed ID: 24519959
[TBL] [Abstract][Full Text] [Related]
13. EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer.
Dunne PD; Dasgupta S; Blayney JK; McArt DG; Redmond KL; Weir JA; Bradley CA; Sasazuki T; Shirasawa S; Wang T; Srivastava S; Ong CW; Arthur K; Salto-Tellez M; Wilson RH; Johnston PG; Van Schaeybroeck S
Clin Cancer Res; 2016 Jan; 22(1):230-242. PubMed ID: 26283684
[TBL] [Abstract][Full Text] [Related]
14. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
[TBL] [Abstract][Full Text] [Related]
15. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of long noncoding RNA ZFAS1 predicts poor prognosis and prompts invasion and metastasis in colorectal cancer.
Wang W; Xing C
Pathol Res Pract; 2016 Aug; 212(8):690-5. PubMed ID: 27461828
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer.
Song Q; Li C; Feng X; Yu A; Tang H; Peng Z; Wang X
Oncol Rep; 2015 Apr; 33(4):1956-64. PubMed ID: 25672935
[TBL] [Abstract][Full Text] [Related]
18. Acetylation of PHF5A Modulates Stress Responses and Colorectal Carcinogenesis through Alternative Splicing-Mediated Upregulation of KDM3A.
Wang Z; Yang X; Liu C; Li X; Zhang B; Wang B; Zhang Y; Song C; Zhang T; Liu M; Liu B; Ren M; Jiang H; Zou J; Liu X; Zhang H; Zhu WG; Yin Y; Zhang Z; Gu W; Luo J
Mol Cell; 2019 Jun; 74(6):1250-1263.e6. PubMed ID: 31054974
[TBL] [Abstract][Full Text] [Related]
19. MFG-E8 overexpression promotes colorectal cancer progression via AKT/MMPs signalling.
Zhao Q; Xu L; Sun X; Zhang K; Shen H; Tian Y; Sun F; Li Y
Tumour Biol; 2017 Jun; 39(6):1010428317707881. PubMed ID: 28653875
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]